Literature DB >> 29756128

Diabetic Retinopathy: Focus on Minority Populations.

Arpine Barsegian1, Boleslav Kotlyar1, Justin Lee2, Moro O Salifu2, Samy I McFarlane2.   

Abstract

Diabetic retinopathy is a major cause of blindness in the United States. With rise of the epidemic of obesity and diabetes in the USA and around the globe, serious and common diabetic complications are evolving as a major public health problem, particularly among minority populations. These populations are disproportionately affected by diabetes and 2-3 times more likely to develop visually significant complications. In this highly illustrated review article, we discuss the diabetic epidemic, highlighting the biology and the pathophysiologic mechanisms of this disorder on the anatomy of the eye. We also discuss the risk factors and the implications for minority populations. For the health care providers, we provide cutting edge information and imminently relevant information to help evaluate, manage, and know when to refer their patients to a specialist in ophthalmology to quell the tide of the epidemic.

Entities:  

Year:  2017        PMID: 29756128      PMCID: PMC5945200          DOI: 10.17352/ijcem.000027

Source DB:  PubMed          Journal:  Int J Clin Endocrinol Metab


  119 in total

1.  Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program.

Authors:  E R Schoenfeld; J M Greene; S Y Wu; M C Leske
Journal:  Ophthalmology       Date:  2001-03       Impact factor: 12.079

2.  The National Eye Health Education Program: increasing awareness of diabetic eye disease among American Indians and Alaska Natives.

Authors:  Karen Silver; Meredith Williams; Everly Macario
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

Review 3.  Dyslipidemia and diabetic retinopathy.

Authors:  Yo-Chen Chang; Wen-Chuan Wu
Journal:  Rev Diabet Stud       Date:  2013-08-10

4.  The prevalence of diabetic retinopathy among adults in the United States.

Authors:  John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman
Journal:  Arch Ophthalmol       Date:  2004-04

5.  Dimensions of patient-provider communication and diabetes self-care in an ethnically diverse population.

Authors:  John D Piette; Dean Schillinger; Michael B Potter; Michele Heisler
Journal:  J Gen Intern Med       Date:  2003-08       Impact factor: 5.128

6.  Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study.

Authors:  Quan Dong Nguyen; Syed Mahmood Shah; Jeffery S Heier; Diana V Do; Jennifer Lim; David Boyer; Prema Abraham; Peter A Campochiaro
Journal:  Ophthalmology       Date:  2009-08-22       Impact factor: 12.079

Review 7.  A clinically useful diabetes electronic medical record: lessons from the past; pointers toward the future.

Authors:  C Gorman; J Looker; T Fisk; W Oelke; D Erickson; S Smith; B Zimmerman
Journal:  Eur J Endocrinol       Date:  1996-01       Impact factor: 6.664

8.  Eye care in African Americans with type 1 diabetes: the New Jersey 725.

Authors:  Monique S Roy
Journal:  Ophthalmology       Date:  2004-05       Impact factor: 12.079

9.  Closing the loop: physician communication with diabetic patients who have low health literacy.

Authors:  Dean Schillinger; John Piette; Kevin Grumbach; Frances Wang; Clifford Wilson; Carolyn Daher; Krishelle Leong-Grotz; Cesar Castro; Andrew B Bindman
Journal:  Arch Intern Med       Date:  2003-01-13

10.  Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT).

Authors:  Nicholas Emanuele; Thomas Moritz; Ronald Klein; Matthew D Davis; Kathleen Glander; Anuradha Khanna; Lizy Thottapurathu; Gideon Bahn; William Duckworth; Carlos Abraira
Journal:  Diabetes Res Clin Pract       Date:  2009-08-31       Impact factor: 5.602

View more
  5 in total

Review 1.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

2.  Genome-wide polygenic risk score for retinopathy of type 2 diabetes.

Authors:  Iain S Forrest; Kumardeep Chaudhary; Ishan Paranjpe; Ha My T Vy; Carla Marquez-Luna; Ghislain Rocheleau; Aparna Saha; Lili Chan; Tielman Van Vleck; Ruth J F Loos; Judy Cho; Louis R Pasquale; Girish N Nadkarni; Ron Do
Journal:  Hum Mol Genet       Date:  2021-05-29       Impact factor: 5.121

3.  Vasant Kusmakar Ras, an ayurvedic herbo-mineral formulation prevents the development of diabetic retinopathy in rats.

Authors:  Sanjay Motilal Tamoli; Kuldip Raj Kohli; Aakruti Arun Kaikini; Suraj Abhimanyu Muke; Afroj Abdulgani Shaikh; Sadhana Sathaye
Journal:  J Ayurveda Integr Med       Date:  2020-04-17

4.  Clinical and Demographic Factors Associated With Diabetic Retinopathy Among Young Patients With Diabetes.

Authors:  Michael L Ferm; Daniel J DeSalvo; Laura M Prichett; James K Sickler; Risa M Wolf; Roomasa Channa
Journal:  JAMA Netw Open       Date:  2021-09-01

5.  Nimbolide ameliorates the streptozotocin-induced diabetic retinopathy in rats through the inhibition of TLR4/NF-κB signaling pathway.

Authors:  Xiangwen Shu; Yali Hu; Chao Huang; Ning Wei
Journal:  Saudi J Biol Sci       Date:  2021-06-19       Impact factor: 4.219

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.